Clinical Trial

Protons vs. Photons for High-risk Prostate Cancer

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess late gastro-intestinal side-effects comparing proton therapy to photon therapy in high-risk prostate cancer patients receiving whole pelvic irradiation.
Protocol Amendment History 4 changes
critical Enrollment closed, study ongoing 2026-08-14
notable Enrollment reduced: 400 -> 102 participants 2026-08-14
notable Primary completion pushed: 2027-03-01 -> 2028-12-01 2026-08-14
minor Completion pushed: 2037-03-01 -> 2038-12-01 2026-08-14
Trial Details
NCT Number NCT05350475
Lead Sponsor University of Aarhus
Collaborators: Rigshospitalet, Denmark, Odense University Hospital, Aarhus University Hospital, Aalborg University Hospital, Sygehus Lillebaelt, Herlev and Gentofte Hospital, Naestved Hospital
Conditions Prostate Cancer, Radiotherapy Side Effect
Enrollment 102 participants
Start Date 2022-03-01
Primary Completion 2028-12-01 (estimated)
Study Completion 2038-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-13